Priveterra Acquisition Corp.
announcedU=S+W/3W=S@11.50
AEON
Capital Structure & Economics
Trust Size$50,300,000
Unit Price$7.00
Warrant Coverage1/3
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
33% Warrant Inclusion| Public Trust Allocation | $50,300,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $7.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedJan 21, 2021
Target AnnouncedDec 12, 2022
Maturation Wall
Feb 11, 2023
Announced Target / M&A
- Target CompanyAEON Biopharma, Inc.
- SectorBiopharmaceuticals
- Announced Deal Size$165,000,000
- Announcement Date2022-12-12
Board & Officers
- Robert BancroftCEO
- Robert PalmisanoOfficer
- Vikram MalikOfficer
- Officer
Advanced Structuring Terms
| Target Sectors | Biopharmaceuticals |
Syndicate & Advisors
- ACM ARRT J LLCLEAD
- LEAD
- LEAD
- LEAD
- LEAD
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.